Search for: "CORNERSTONE PHARMACEUTICALS, INC."
Results 1 - 20
of 29
Sort by Relevance
|
Sort by Date
18 Apr 2023, 5:35 am
Vital Pharmaceuticals, Inc., 2023 WL 2918724, No. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
28 Oct 2020, 6:30 am
Author Rebecca Shafer, JD, President of Amaxx Risk Solutions, Inc. is a national expert in the field of workers compensation. [read post]
11 Aug 2020, 6:30 am
Purpose of Training Training is the cornerstone of formal employee communication. [read post]
3 Mar 2020, 4:00 am
In Novartis Pharmaceuticals Canada Inc. v. [read post]
5 Aug 2019, 11:03 am
Supreme Court issued a unanimous opinion in Cyan Inc. v. [read post]
11 Oct 2018, 12:57 am
The court examined the description in detail and highlighted that it unambiguously describes a pharmaceutical composition that contains the combination of ezetimibe and a cholesterol biosynthesis inhibitor. [read post]
11 Feb 2018, 2:35 pm
Synergy is not only a life sciences company but it is in SIC Code 2834 (Pharmaceutical Preparations). [read post]
2 Jan 2018, 5:08 pm
The world of directors’ and officers’ liability is always dynamic, but 2017 was a particularly eventful year in the D&O liability arena. [read post]
25 Jul 2017, 8:28 am
Supreme Court in its upcoming term, in the Cyan, Inc. v. [read post]
20 Feb 2017, 7:02 am
(“Medpace”), a pharmaceutical research facility, hired Dr. [read post]
22 Feb 2016, 4:36 pm
After attending the PLUS D&O Symposium some years ago, several colleagues at Partner Re thought it might be worthwhile to provide D&O insurance professionals with historical overview of the evolution of Directors and Officers insurance (D&O) in the US marketplace. [read post]
13 Apr 2015, 4:22 am
PwC’s report is generally consistent with the reports previously published by Cornerstone Research and NERA. [read post]
12 Feb 2015, 5:02 am
The Department of Justice (DOJ) announced on January 9, 2015, that Daiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the United States and state Medicaid programs $39 million to resolve allegations that it violated the False Claims Act. [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
27 Oct 2014, 5:27 am
* Obviousness, common general knowledge and expectations of success: Leo gets a mauling Jeremy hosts this post by Suleman Ali (Holly IP) on Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat), a decision by Mr Justice Birss in the Patents Court, England and Wales which addresses two patent law cornerstones: obviousness and common general knowledge. [read post]
11 Aug 2013, 7:45 pm
EKR Therapeutics, LLC et al. 5:13-cv-00111; filed August 8, 2013 in the Western District of North Carolina • Plaintiff: Exela Pharma Sciences, LLC • Defendants: EKR Therapeutics, LLC; Cornerstone Therapeutics Inc.; Cornerstone BioPharma, Inc. [read post]
28 Jul 2013, 8:52 pm
Cornerstone Therapeutics Inc. et al. v. [read post]
13 May 2013, 8:35 am
Purpose of Training Training is the cornerstone of formal employee communication. [read post]
29 May 2012, 10:06 am
Cornerstone Therapeutics, Inc., 2012 WL 1835671 (W.D.N.Y.) [read post]
